SPC
CLBT icon

Sigma Planning Corp’s Cellebrite CLBT Stock Holding History

Sigma Planning Corp’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,000
Closed -$384K – 1309
2025
Q2 		$384K Buy
24,000
+12,000
+100% +$214K 0.01% 888
2025
Q1 		$233K Buy
+12,000
New +$253K 0.01% 1062

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Sigma Planning Corp's CLBT Position: Q3 2025 in Review

Sigma Planning Corp sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 24,000 shares — an estimated $384K sold.

Sigma Planning Corp first reported a position in CLBT in Q1 2025 and held it in 2 quarters. The position peaked at $384K in Q2 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Sigma Planning Corp reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 24,000 Cellebrite shares in Q3 2025, an estimated $384K.
  • Sigma Planning Corp first reported a position in Cellebrite in Q1 2025 and held it in 2 quarters.
  • Sigma Planning Corp's Cellebrite position peaked at $384K in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Sigma Planning Corp's 13F filing for Q3 2025, filed 10 Nov 2025.